Efficacy of DA-5204 on Gastroesophageal Reflux Disease

NCT03998969 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Disease

Interventions

DRUG: Pantoprazole
DRUG: DA-5204
DRUG: Placebo

Sponsor

Seoul National University Hospital

Collaborators

[object Object]